Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193805-24-001313
Filing Date
2024-11-06
Accepted
2024-11-06 21:02:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13g10871ttoo_11062024.htm SC 13G 78356
2 ex991tosc13g10871ttoo_110624.htm EX-99.1 3601
  Complete submission text file 0001193805-24-001313.txt   83499
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Subject) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88541 | Film No.: 241432776
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address ONE STATE STREET PLAZA NEW YORK NY 10004
Business Address ONE STATE STREET PLAZA NEW YORK NY 10004 (212) 412-9190
JSAF Holdings, LLC (Filed by) CIK: 0002034632 (see all company filings)

EIN.: 993819812 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G